Press Release: Spinal Modulation : Spinal Modulation Completes Enrollment of Its Landmark U.S. Pivotal Trial Evaluating the Axium Neurostimulator System for Chronic Pain

MENLO PARK, Calif.--(BUSINESS WIRE)--Spinal Modulation has completed enrollment of the ACCURATE study, a clinical trial designed to evaluate the safety and efficacy of the company's Axium Neurostimulator System.